Earlier this year, Health Incubator Helsinki opened its 7th application round. The new batch of high-potential health startups is now selected – meet the teams!

Health Incubator Helsinki, Finland’s first incubator program dedicated to health startups, has selected its seventh batch of promising companies. Interest in the program was exceptionally strong this year: the call attracted more than 50 applications from teams in Finland and around the world.

After a thorough selection process, the following companies were chosen: Alveos, ChainPeptides, Cornea Sense, HumGel, Long Play Lab Finland, Onni Biotechnologies, Ounas Health, Rayca Precision, VeinOptima and Wellmatix.

“The selected 10 companies represent exceptional dedication, strong growth potential, and scalable business models”, says Christian Lardot, Incubator Lead at Health Incubator Helsinki.

Tailored support and strong networking opportunities

The incubator program, initiated by Business Helsinki and the University of Helsinki, provides long-term support for startups, including tailored mentoring and advice. Teams are offered office and co-working facilities at Terkko Health Hub, next to HUS Helsinki University Hospital. Since autumn 2025, selected companies in the program have also had the opportunity to access laboratory facilities at Biomedicum.

New teams begin with a two-month onboarding phase focused on developing their concept and raising capital. After that, the support shifts to a more tailored, company-specific approach, based on each team’s needs and stage of development.

Participants also gain access to a network of over 150 organizations, including local and international investors and industry-specific experts.

“According to our customer satisfaction surveys, companies highly value the broad range of support we provide in securing financing. The connections we offer, along with the opportunity to learn from other startups in the program, are also highly appreciated,” Lardot says.

Meet the 2026 batch of Health Incubator Helsinki startups

Alveos
Alveos is a health tech startup developing a wearable that empowers people to steer their state for stress, recovery, and performance through real-time breath monitoring and AI guidance.

ChainPeptides
ChainPeptides has developed an antimicrobial peptide technology platform that can be used in medical devices to minimize the incidence and severity of chronic wounds. The company is currently developing Chain Smart Plaster to address unmet needs in the treatment of diabetic foot ulcers.

Cornea Sense
Cornea Sense pioneers the first non-contact way to measure corneal hydration, adding a new quantitative signal to routine eye exams.

HumGel
HumGel is a biotech company developing the world’s first human-tumor-derived extracellular matrices to replace animal-based materials. The company’s products provide more accurate and human-relevant results for cancer research and drug development.

Long Play Lab Finland
Long Play Lab Finland’s wellbeing prescribing platform, SolmuRx, connects referrers, participants and providers to social, cultural and nature-based prescriptions.

Onni Biotechnologies
Onni Biotechnologies develops a new NK cell immunotherapy for hard-to-treat cancers. The company’s patented FasL-enhanced platform improves tumour killing. Currently, the company is carrying out preclinical studies of its drug candidate ONNI-1.

Ounas Health
Ounas Health is developing a Clinical Intelligence Platform that transforms fragmented healthcare data into actionable clinical insights.

Rayca Precision
Rayca’s AI rapidly designs, screens and optimizes thousands of therapeutic candidates for hard-to-drug targets, advancing its owned and partnered pipelines from concept to IND approval.

VeinOptima
VeinOptima is an advanced vein monitor device designed to help clinicians locate veins faster in patients such as children, elderly patients, and those with severe diseases who have difficult venous access.

Wellmatix
Wellmatix is an AI-powered Therapeutics discovery company developing next-generation Antibody-Drug Conjugate (ADC) platforms. Its proprietary algorithms accelerate early-stage discovery, reduce costs, and improve success rates in oncology and immunotherapy development.

Contact information

Christian Lardot, Health Incubator Helsinki Lead
Tel. +358 40 195 2639
christian.lardot@hel.fi

About Health Incubator Helsinki

Health Incubator Helsinki is a comprehensive incubator program in Finland for research-based, early-stage teams and startups operating in the health sector. The incubator, initiated by Business Helsinki and the University of Helsinki, and provided in partnership with Health Capital Helsinki, started operations in 2020. It is part of a consortium that supports startups and research-based teams from universities and SPRAK Finland to develop their health and life sciences innovations and business concepts towards becoming growth companies.

Photo: Roope Permanto